Skip to main content
Tag

Quality of life

All.Can infographic answers why efficient cancer care matters

By News archive

A new infographic published by the All.Can initiative explains why cancer care efficiency matters and how it can be improved. As highlighted in the graphic, efficient cancer care delivers the best possible health outcomes using the human, financial, infrastructural and technological resources available. As well as highlighting the many negative consequences of inefficient cancer care, the graphic illustrates six ways in which greater efficiency can be achieved in cancer care.

All.Can was an initiative established in 2016, in which the IBTA is a founding member, and is a global, multi-stakeholder initiative to inform and generate political and public engagement on the need to improve efficiency in cancer care, by focusing on what really matters to patients and society. All.Can seeks to make sure resources are directed towards achieving better health outcomes while contributing to health systems’ overall sustainability.

Download the full infographic here.

Read more on the All.Can website here.

IBTA COVID-19 Survey published in Neuro-Oncology Advances

By IBTA News

The IBTA announces that the results of the IBTA’s survey: ‘Brain tumours and COVID-19: the patient and caregiver experience‘ have been published in the journal Neuro-Oncology Advances.

In April and May 2020, the IBTA, as part of its work with the Society for Neuro-Oncology (SNO) COVID-19 Task Force carried out the first international survey within the global community of brain tumour patients and caregivers on how the COVID-19 pandemic had directly affected them. The survey results have now been published in Neuro-Oncology Advances. In total, 1,989 participants completed the survey from 33 countries including 1,459 patients and 530 caregivers.

Among the findings, the survey found that while this pandemic has been an extremely stressful time for this population, caregivers were significantly more anxious than patients.

Furthermore, from those polled, respondents in the Americas were found to have been most likely to have lost their jobs, practiced self-isolation, and received telehealth services. When asked to rank the most trusted sources of information during the pandemic, healthcare providers, brain tumour charities, and not-for-profits were the most trusted.

The results serve as a rich resource of data and personal testimonials to help individuals and organisations in the brain tumour community to ensure they continue to fulfil patients’ expectations and retain patients’ trust by providing accessible, high-quality care, information, and support.

Lead author, neurosurgeon Dr Mathew Voisin (Toronto, Canada) said: “Among the wealth of information collected through the survey, the results revealed that because of COVID-19, brain tumour patients and caregivers experienced a significant amount of stress and anxiety.”

The paper’s co-authors include the IBTA’s Chair Kathy Oliver, Dr Gelareh Zadeh, Tess Chee and IBTA Senior Advisors: Dr Stuart Farrimond, Jean Arzbaecher, Carol Kruchko, Mary Ellen Maher, Chris Tse, Rosemary Cashman, Maureen Daniels, Christine Mungoshi, Sharon Lamb, Anita Granero, Dr Mary Lovely, Jenifer Baker and  Sally Payne. Read the full article online here (free access to the PDF).

UPDATE 29th October 2020: A lay (plain language) summary of the survey’s findings (right) has now been published and can be downloaded here.

First findings of All.Can patient survey presented at UK Parliament event

By IBTA News

The All.Can initiative has presented the first findings of its UK patient survey at a UK Parliamentary event. They showed that 36% of people considered the cancer diagnosis stage as the biggest cause of inefficiency in their care. Two in five people with cancer had been initially misdiagnosed with something else – sometimes on multiple occasions – and one in five had to wait more than six months for a cancer diagnosis.

The findings were presented at the Britain Against Cancer conference, hosted by the All-Party Parliamentary Group on Cancer. The event took place on 4 December at the UK Parliament in London. The UK national initiative is the first of nine countries to release findings from the All.Can patient survey, which sought patients’ and carers’ perspectives on inefficiencies in cancer care.

All.Can is an international multi-stakeholder policy initiative that is focused on improving efficiency in cancer care, in which the IBTA is one of the stakeholder organisations. The UK national initiative is the first of nine countries to release findings from the All.Can patient survey. A report of the findings from all countries is due to be published in early 2019. Read more.